Article thumbnail

Biochemical Properties of Highly Neuroinvasive Prion Strains

By Cyrus Bett, Shivanjali Joshi-Barr, Melanie Lucero, Margarita Trejo, Pawel Liberski, Jeffery W. Kelly, Eliezer Masliah and Christina J. Sigurdson


Infectious prions propagate from peripheral entry sites into the central nervous system (CNS), where they cause progressive neurodegeneration that ultimately leads to death. Yet the pathogenesis of prion disease can vary dramatically depending on the strain, or conformational variant of the aberrantly folded and aggregated protein, PrPSc. Although most prion strains invade the CNS, some prion strains cannot gain entry and do not cause clinical signs of disease. The conformational basis for this remarkable variation in the pathogenesis among strains is unclear. Using mouse-adapted prion strains, here we show that highly neuroinvasive prion strains primarily form diffuse aggregates in brain and are noncongophilic, conformationally unstable in denaturing conditions, and lead to rapidly lethal disease. These neuroinvasive strains efficiently generate PrPSc over short incubation periods. In contrast, the weakly neuroinvasive prion strains form large fibrillary plaques and are stable, congophilic, and inefficiently generate PrPSc over long incubation periods. Overall, these results indicate that the most neuroinvasive prion strains are also the least stable, and support the concept that the efficient replication and unstable nature of the most rapidly converting prions may be a feature linked to their efficient spread into the CNS

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). A change in the conformation of prions accompanies the emergence of a new prion strain.
  2. (2007). A general model of prion strains and their pathogenicity.
  3. (2010). A size threshold limits prion transmission and establishes phenotypic diversity.
  4. (2007). Accumulation of prion protein in the brain that is not associated with transmissible disease.
  5. (1985). Agent replication dynamics in a long incubation period model of mouse scrapie.
  6. (2001). Aguzzi A
  7. (2009). An analytical solution to the kinetics of breakable filament assembly.
  8. (2009). Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22 L and in the lymphoreticular system in vivo.
  9. (1992). Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.
  10. (1998). Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie.
  11. (2001). Complement facilitates early prion pathogenesis.
  12. (2004). Conformational variations in an infectious protein determine prion strain differences.
  13. (2006). Continuum of prion protein structures enciphers a multitude of prion isolatespecified phenotypes.
  14. (2011). Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.
  15. (2008). Cryoimmunogold electron microscopy for prions: toward identification of a conversion site.
  16. (2009). De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.
  17. (2008). Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.
  18. (2005). Diagnosis of human prion disease.
  19. (2006). Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations.
  20. (1998). Eight prion strains have PrP Sc molecules with different conformations.
  21. (2003). Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility.
  22. (2007). Formation of native prions from minimal components in vitro.
  23. (2010). Generating a prion with bacterially expressed recombinant prion protein.
  24. (2004). Human prion protein with valine 129 prevents expression of variant CJD phenotype.
  25. (1997). In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies.
  26. (1988). Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system.
  27. (2006). Isolation and Characterization of a Proteinase K-Sensitive PrP(Sc) Fraction.
  28. (1985). Long-term persistence of scrapie infection in mouse spleens in the absence of clinical disease.
  29. (2004). Mammalian prion biology. One century of evolving concepts.
  30. (1998). Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent.
  31. (2007). Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc.
  32. (1982). Novel proteinaceous infectious particles cause scrapie.
  33. (1986). Pathogenesis of scrapie (strain 263 K) in hamsters infected intracerebrally, intraperitoneally or intraocularly.
  34. (1989). Pathogenesis of scrapie in mice after intragastric infection.
  35. (2003). Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion.
  36. (1989). Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie.
  37. (2006). Prions and their lethal journey to the brain.
  38. (2008). Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD.
  39. (2002). Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.
  40. (2011). Proteasesensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
  41. (2003). Protofibrils, Pores, Fibrils, and Neurodegeneration: Separating the Responsible Protein Aggregates from the Innocent Bystanders.
  42. (1998). PrP expression in B lymphocytes is not required for prion neuroinvasion.
  43. (2003). Rapid prion neuroinvasion following tongue infection.
  44. (2010). Recombinant prion protein induces a new transmissible prion disease in wildtype animals.
  45. (1992). Regional mapping of prion proteins in brain.
  46. (2002). Retrograde transport of transmissible mink encephalopathy within descending motor tracts.
  47. (1973). Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.
  48. (1991). Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.
  49. (1983). Scrapie prions aggregate to form amyloid-like birefringent rods.
  50. (2006). Strain fidelity of chronic wasting disease upon murine adaptation.
  51. (2001). Strainspecified relative conformational stability of the scrapie prion protein.
  52. (2007). Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.
  53. (2011). Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange.
  54. (2002). Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain.
  55. (2001). Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.
  56. (2000). Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie [letter].
  57. (2011). The amyloid-Congo red interface at atomic resolution.
  58. (1991). The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis.
  59. (2005). The most infectious prion protein particles.
  60. (2006). The physical basis of how prion conformations determine strain phenotypes.
  61. (2010). The physical relationship between infectivity and prion protein aggregates is strain-dependent.
  62. (2008). The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.
  63. (1968). The sequential development of the brain lesion of scrapie in three strains of mice.
  64. (2011). The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease.
  65. (2003). The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease.
  66. (2001). Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay.
  67. (2011). Transgenic mouse models and prion strains.
  68. (2000). Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.